{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.1017","meta":{"versionId":"5","lastUpdated":"2022-07-13T01:02:20.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Clinical Architecture"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-06-21"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-07-13"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1017","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.3616.200.110.102.1017"}],"version":"20220713","name":"TocilizumabAdministration","title":"Tocilizumab Administration","status":"retired","experimental":false,"date":"2023-06-21T18:16:37-04:00","publisher":"Clinical Architecture","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains terms related to intravenous administration of tocilizumab.),(Data Element Scope: ),(Inclusion Criteria: Includes terms related to intravenous administration of tocilizumab.),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"J3262","display":"Injection, tocilizumab, 1 mg"},{"code":"M0249","display":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose"},{"code":"M0250","display":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose"},{"code":"Q0249","display":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg"}]}]},"expansion":{"identifier":"urn:uuid:415023e0-b250-4275-8bf1-73341873e30a","timestamp":"2023-12-11T01:34:10-05:00","total":4,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J3262","display":"Injection, tocilizumab, 1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"M0249","display":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"M0250","display":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"Q0249","display":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg"}]}}